Sattva S Neelapu (Sattva Neelapu)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 61

Top Venues

Blood advances

Nature communications

Nature cancer

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer 5 (7) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, John S Tamaresis, Armin Ghobadi, Yi Lin, Lazaros Lekakis, Patrick Reagan, Olalekan O Oluwole, Joseph P McGuirk, Abhinav Deol, Kathleen A Dorritie, Alison R Sehgal, Andre H Goy, Brian T Hill, Charalambos Andreadis, Javier L Muñoz, Matthew L Ulrickson, Jason R Westin, Julio C Chavez, Dilan A Patel, Miriam T Jacobs, Radhika Bansal, N Nora Bennani, Vivek G Patel, Aaron P Rapoport, Julie M Vose, David Bernard Miklos, Sattva S Neelapu, Frederick L Locke, Matthew Lunning, Saurabh Dahiya
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, John S Tamaresis, Armin Ghobadi, Yi Lin, Lazaros Lekakis, Patrick Reagan, Olalekan O Oluwole, Joseph P McGuirk, Abhinav Deol, Kathleen A Dorritie, Alison R Sehgal, Andre H Goy, Brian T Hill, Charalambos Andreadis, Javier L Muñoz, Matthew L Ulrickson, Jason R Westin, Julio C Chavez, Dilan A Patel, Miriam T Jacobs, Radhika Bansal, N Nora Bennani, Vivek G Patel, Aaron P Rapoport, Julie M Vose, David Bernard Miklos, Sattva S Neelapu, Frederick L Locke, Matthew Lunning, Saurabh Dahiya
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Anath C Lionel, Sattva S Neelapu
CAR T-cell expansion: harmful or helpful? Blood advances 8 (12) (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Anath C Lionel, Sattva S Neelapu
CAR T-cell expansion: harmful or helpful? Blood advances 8 (12) (2024)
Anath C Lionel, Sattva S Neelapu
CAR T-cell expansion: harmful or helpful? Blood advances 8 (12) (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer (2024)
Paolo Strati, Oren Pasvolsky, Lei Feng, Guofan Xu, Sanjit Tewari, Jaimole Varghese, Karla Ow, Minifrida Sibug Santiago, Ajlan Al Zaki, Andrew Jallouk, Sattva S Neelapu, Partow Kebriaei, Elizabeth J Shpall, Sairah A Ahmed
ASCT vs CART for Patients with Relapsed LBCL in PR: Role of TMTV. Blood advances (2023)
Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, David Bernard Miklos, Lazaros J Lekakis, Olalekan O Oluwole, Yi Lin, Ira Braunschweig, Brian T Hill, John M Timmerman, Abhinav Deol, Patrick M Reagan, Patrick Joseph Stiff, Ian W Flinn, Umar Farooq, Andre H Goy, Peter McSweeney, Javier L Muñoz, Tanya Siddiqi, Julio C Chavez, Alex F Herrera, Nancy L Bartlett, Adrian A Bot, Rhine R Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J Kim, Yan Zheng, Frederick L Locke
5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1). Blood (2023)
Larry W Kwak, Szymon Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottham, Sheetal Rao, Jasper Olsem, Brandon Crumpton, Hans C Lee, Elisabet Manasanch, Sattva S Neelapu, Sheeba Thomas
First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma. Research square (2023)
Paolo Strati, Andrew P Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E Steiner, Sairah A Ahmed, Dai Chihara, Luis E Fayad, Swaminathan P Iyer, Sandra B Horowitz, Loretta J Nastoupil, Ranjit Nair, Ahmed Hassan, Taher Daoud, Misha Hawkins, Maria A Rodriguez, Elizabeth J Shpall, Jeremy Leon Ramdial, Partow Kebriaei, David S Hong, Jason R Westin, Sattva S Neelapu, Michael R Green
A Phase I Study of Prophylactic Anakinra to Mitigate ICANS in Patients with Large B-cell Lymphoma. Blood advances (2023)
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E Fayad, Sairah Ahmed, Swaminathan P Iyer, Raphael E Steiner, Preetesh Jain, Loretta J Nastoupil, Jason R Westin, Reetakshi Arora, Michael L Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Muller-Tidow, Frederick L Locke, Marco L Davila, Richard E Champlin, Christopher R Flowers, Elizabeth J Shpall, Hendrik Poeck, Sattva S Neelapu, Michael Schmitt, Marion Subklewe, Michael D Jain, Robert R Jenq, Eran Elinav
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nature medicine (2023)
Fuliang Chu, Jingjing Cao, Jingwei Liu, Haopeng Yang, Timothy J Davis, Shao-Qing Kuang, Xiaoyun Cheng, Zheng Zhang, Swathi Karri, Long T Vien, Laura Bover, Ryan Sun, Francisco Vega, Michael Green, Richard Eric Davis, Sattva S Neelapu
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. Journal for immunotherapy of cancer 11 (11) (2023)
Yucai Wang, Preetesh Jain, Frederick L Locke, Matthew John Maurer, Matthew J Frank, Javier L Muñoz, Saurabh Dahiya, Amer M Beitinjaneh, Miriam T Jacobs, Joseph P McGuirk, Julie M Vose, Andre H Goy, Charalambos Andreadis, Brian T Hill, Kathleen A Dorritie, Olalekan O Oluwole, Abhinav Deol, Jonas Paludo, Bijal Shah, Trent P Wang, Rahul Banerjee, David Bernard Miklos, Aaron P Rapoport, Lazaros Lekakis, Armin Ghobadi, Sattva S Neelapu, Yi Lin, Michael L Wang, Michael D Jain
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sattva S Neelapu, Julio C Chavez, Alison Sehgal, Narendranath Epperla, Matthew L Ulrickson, Emmanuel Bachy, Pashna Munshi, Carla Casulo, David G Maloney, Sven de Vos, Ran Reshef, Lori A Leslie, Olalekan O Oluwole, Ibrahim Yakoubagha, Rashmi Khanal, Joseph D Rosenblatt, Ronald Korn, Weixing Peng, Christine Lui, Jacob Wullf, Rhine R Shen, Soumya Poddar, A Scott Jung, Harry Miao, Sara Beygi, Caron A Jacobson
Three-Year Follow-Up Analysis of Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5). Blood (2023)
John G Gribben, M Lia Palomba, Anik R Patel, Myrna Nahas, Sattva S Neelapu
Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma. Blood advances (2023)
Michael D Jain, Miriam T Jacobs, Feng Gao, Loretta J Nastoupil, Jay Y Spiegel, Yi Lin, Saurabh Dahiya, Matthew A Lunning, Lazaros J Lekakis, Patrick M Reagan, Olalekan O Oluwole, Joseph P McGuirk, Abhinav Deol, Alison Sehgal, Andre H Goy, Brian T Hill, Charalambos Andreadis, Javier L Muñoz, Julio C Chavez, N Nora Bennani, Aaron P Rapoport, Julie M Vose, David Bernard Miklos, Sattva S Neelapu, Frederick L Locke, Armin Ghobadi
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: Results from the US lymphoma CAR-T consortium. Blood advances (2023)
Mario L Marques-Piubelli, Edwin R Parra, Lei Feng, Luisa Maren Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B Hagemeister, Jason R Westin, Hun Ju Lee, Maria A Rodriguez, Sattva S Neelapu, Jillian R Gunther, Nathan H Fowler, Christopher R Flowers, Ignacio I Wistuba, Loretta J Nastoupil, Francisco Vega, Paolo Strati
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab. Blood advances 6 (11) (2022)
Hua-Jay Jeffery Cherng, Stefan Alig, Yasuhiro Oki, Loretta J Nastoupil, Luis E Fayad, Sattva S Neelapu, Francesco Turturro, Fredrick B Hagemeister, Alexander Craig, Charles W Macaulay, Maria A Rodriguez, Hun Ju Ju Lee, Timothy McDonnell, Christopher R Flowers, Francisco Vega, Michael R Green, Lei Feng, David M Kurtz, Ash A Alizadeh, Richard Eric Davis, Jason R Westin
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL. Blood advances (2022)
Neeraj Saini, Sattva S Neelapu
CAR T r e g cells: prime suspects in therapeutic resistance. Nature medicine 28 (9) (2022)
Paola Ghione, M Lia Palomba, Anik R Patel, Sabela Bobillo, Kevin Deighton, Caron A Jacobson, Myrna Nahas, Anthony James Hatswell, A Scott Jung, Steve Kanters, Julia Thornton Snider, Sattva S Neelapu, Maria Teresa Ribeiro, M Alan Brookhart, Herve Ghesquieres, John Radford, John G Gribben
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma. Blood 140 (8) (2022)
Tianyu Cai, Agnès Gouble, Kathryn L Black, Anna Skwarska, Ammar S Naqvi, Deanne M Taylor, Ming Zhao, Yuan Qi, Mayumi Sugita, Qi Zhang, Roman Galetto, Stéphanie Filipe, Antonio Cavazos, Lina Han, Vinitha Kuruvilla, Helen Ma, Connie Weng, Chang-Gong Liu, Xiuping Liu, Sergej Konoplev, Jun Gu, Guilin Tang, Xiaoping Su, Gheath Al-Atrash, Stefan Ciurea, Sattva S Neelapu, Andrew A Lane, Hagop M Kantarjian, Monica L Guzman, Naveen Pemmaraju, Julianne Smith, Andrei Thomas-Tikhonenko, Marina Y Konopleva
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nature communications 13 (1) (2022)
Loretta J Nastoupil, Collin K Chin, Jason R Westin, Nathan H Fowler, Felipe Samaniego, Xiaoyun Cheng, Man Chun John Ma, Zhiqiang Wang, Fuliang Chu, Ly Dsouza, Chizobam Obi, Jennifer Mims, Lei Feng, Shouhao Zhou, Michael Green, Richard Eric Davis, Sattva S Neelapu
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. Blood advances 6 (4) (2022)
Jason R Westin, R Eric Davis, Lei Feng, Fredrick B Hagemeister, Raphael Steiner, Jee Hun Lee, Luis Fayad, Loretta Nastoupil, Sairah Ahmed, Maria A Rodriguez, Michelle Fanale, Felipe Samaniego, Swaminathan P Iyer, Ranjit Nair, Yasuhiro Oki, Nathan Fowler, Michael L Wang, Man Chun John Ma, Francisco Vega, Timothy McDonnell, Chelsea Pinnix, Donna Griffith, Yang Lu, Sanjit O Tewari, Ryan Sun, David W Scott, Christopher R Flowers, Sattva S Neelapu, Michael R Green
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 13 (1) (2022)
Nathalie Scholler, Regis Perbost, Frederick L Locke, Michael D Jain, Sarah Turcan, Corinne Danan, Edmund C Chang, Sattva S Neelapu, David Bernard Miklos, Caron A Jacobson, Lazaros J Lekakis, Yi Lin, Armin Ghobadi, Jenny J Kim, Justin Chou, Vicki Plaks, Zixing Wang, Allen Xue, Mike Mattie, John M Rossi, Adrian Bot, Jerome Galon
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma. Nature medicine 28 (9) (2022)
Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah A Ahmed, Haleigh Mistry, Loretta J Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P Iyer, Hun J Lee, Raphael E Steiner, Christopher R Flowers, Elizabeth J Shpall, Partow Kebriaei, Sattva S Neelapu, Jason R Westin, Paolo Strati
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy. Blood advances 6 (9) (2022)
Sushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, Andrew Ip, Manali K Kamdar, Brian Hess, Lei Feng, Grace Watson, Amy Ayers, Sattva S Neelapu, Arushi Khurana, Yi Lin, Madiha Iqbal, Reid W Merryman, Paolo Strati
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy. Blood advances 6 (9) (2022)
Paolo Strati, Andrew P Jallouk, Ryan Sun, Jaihee Choi, Kaberi Das, Hua-Jay Cherng, Sairah A Ahmed, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Raphael E Steiner, Chad D Huff, Yao Yu, Haleigh Mistry, Brittany Pulsifer, Mansoor Noorani, Neeraj Saini, Elizabeth J Shpall, Partow Kebriaei, Christopher R Flowers, Jason R Westin, Michelle A T Hildebrandt, Sattva S Neelapu
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. Leukemia 36 (11) (2022)
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, Junsheng Ma, Romil D Patel, Kartik Devashish, Kaberi Das, Mark R Tanner, Paolo Strati, Ranjit Nair, Luis Fayad, Sairah A Ahmed, Hun Ju Lee, Swaminathan P Iyer, Raphael E Steiner, Nitin Jain, Loretta Nastoupil, Sanam Loghavi, Guilin Tang, Roland L Bassett, Preetesh Jain, Michael L Wang, Jason R Westin, Michael R Green, David A Sallman, Eric Padron, Marco L Davila, Frederick L Locke, Richard E Champlin, Guillermo Garcia-Manero, Elizabeth J Shpall, Partow Kebriaei, Christopher R Flowers, Michael D Jain, Feng Wang, Andrew P Futreal, Nancy Gillis, Sattva S Neelapu, Koichi Takahashi
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. Blood cancer discovery 3 (5) (2022)
Guangchun Han, Qing Deng, Mario L Marques-Piubelli, Enyu Dai, Minghao Dang, Man Chun John Ma, Xubin Li, Haopeng Yang, Jared Henderson, Olga Mikhaylovna Plotnikova, Mark Meerson, Sergey Isaev, Nikita Kotlov, Krystle J Nomie, Alexander V Bagaev, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Simrit Parmar, Fredrick B Hagemeister, Sairah A Ahmed, Swaminathan P Iyer, Felipe Samaniego, Raphael E Steiner, Luis Fayad, Jee Hun Lee, Nathan Hale Fowler, Christopher R Flowers, Paolo Strati, Jason R Westin, Sattva S Neelapu, Loretta J Nastoupil, Francisco Vega, Linghua Wang, Michael R Green
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression. Blood cancer discovery 3 (5) (2022)
Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang, Cuong Cao Le, Qing Deng, Luis Fayad, Nathan H Fowler, Simrit Parmar, Raphael E Steiner, Fredrick Hagemeister, Ranjit Nair, Hun Ju Lee, Maria A Rodriguez, Felipe Samaniego, Swaminathan P Iyer, Christopher R Flowers, Linghua Wang, Loretta J Nastoupil, Sattva S Neelapu, Sairah A Ahmed, Paolo Strati, Michael R Green, Jason R Westin
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma. Blood 140 (5) (2022)
Sattva S Neelapu, Michael J Dickinson, Javier Munoz, Matthew L Ulrickson, Catherine Thieblemont, Olalekan O Oluwole, Alex F Herrera, Chaitra S Ujjani, Yi Lin, Peter A Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C Chavez
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial. Nature medicine 28 (4) (2022)
Paolo Strati, Sattva S Neelapu
CAR-T failure: beyond antigen loss and T cells. Blood 137 (19) (2021)
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, Patrick M Reagan, David Bernard Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin, Michael Crump, John Kuruvilla, Eric Van Den Neste, Umar Farooq, Lynn Navale, Venita DePuy, Jenny J Kim, Christian Gisselbrecht
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma. Blood advances 5 (20) (2021)
Emma Catherine Morris, Sattva S Neelapu, Theodoros Giavridis, Michel Sadelain
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nature reviews. Immunology (2021)
Patrick M Reagan, Sattva S Neelapu
How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (5) (2021)
Dristhi Ragoonanan, Sajad Jawad Khazal, Hisham Abdel-Azim, David C McCall, Branko Cuglievan, Francesco Paolo Tambaro, Ali Haider Ahmad, Courtney M Rowan, Cristina Gutierrez, Keri Schadler, Shulin Li, Matteo Di Nardo, Linda Chi, Alison M Gulbis, Basirat Shoberu, Maria E Mireles, Jennifer McArthur, Neena Kapoor, Jeffrey Miller, Julie C Fitzgerald, Priti Tewari, Demetrios Petropoulos, Jonathan B Gill, Christine N Duncan, Leslie E Lehmann, Sangeeta Hingorani, Joseph R Angelo, Rita D Swinford, Marie E Steiner, Fiorela N Hernandez Tejada, Paul L Martin, Jeffery Auletta, Sung Won Choi, Rajinder P S Bajwa, Natalie J M Dailey Garnes, Partow Kebriaei, Katayoun Rezvani, William G Wierda, Sattva S Neelapu, Elizabeth J Shpall, Selim Corbacioglu, Kris Michael Mahadeo
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nature reviews. Clinical oncology 18 (7) (2021)
Vicki Plaks, John M Rossi, Justin Chou, Linghua Wang, Soumya Poddar, Guangchun Han, Zixing Wang, Shao-Qing Kuang, Fuliang Chu, Richard E Davis, Francisco Vega, Zahid Bashir, Caron A Jacobson, Frederick L Locke, Patrick M Reagan, Scott J Rodig, Lazaros J Lekakis, Ian W Flinn, David Bernard Miklos, Adrian Bot, Sattva S Neelapu
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel. Blood 138 (12) (2021)
Omar Mamlouk, Ranjit Nair, Swaminathan P Iyer, Angelina Edwards, Sattva S Neelapu, Raphael E Steiner, Sherry A Adkins, Misha Hawkins, Neeraj Saini, Kartik Devashish, Paolo Strati, Sreedhar A Mandayam, Sairah A Ahmed
Safety of CAR T-cell therapy in kidney transplant recipients. Blood 137 (18) (2021)
Paolo Strati, Sairah A Ahmed, Fateeha Furqan, Luis E Fayad, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael L Wang, Chelsea C Pinnix, Sandra B Horowitz, Lei Feng, Ryan Sun, Catherine M Claussen, Misha C Hawkins, Nicole A Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J Shpall, Michael R Green, Christopher R Flowers, Jason R Westin, Sattva S Neelapu
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood 137 (23) (2021)
Uri Greenbaum, Paolo Strati, Rima M Saliba, Janet Torres, Gabriela Rondon, Yago L Nieto, Chitra Hosing, Samer A Srour, Jason R Westin, Luis E Fayad, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael L Wang, Chelsea C Pinnix, Christopher R Flowers, Sudhakar Tummala, Jeremy L Ramdial, Fevzi F Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E Champlin, Elizabeth J Shpall, Sattva S Neelapu, Partow Kebriaei, Sairah A Ahmed
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood advances 5 (14) (2021)
Deanna L Lane, Sattva S Neelapu, Guofan Xu, Olena O Weaver
COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT. Korean journal of radiology 22 (12) (2021)
Qing Deng, Guangchun Han, Nahum Puebla-Osorio, Man Chun John Ma, Paolo Strati, Beth Chasen, Enyu Dai, Minghao Dang, Neeraj Jain, Haopeng Yang, Yuanxin Wang, Shaojun Zhang, Ruiping Wang, Runzhe Chen, Jordan Showell, Sreejoyee Ghosh, Sridevi Patchva, Qi Zhang, Ryan Sun, Frederick Hagemeister, Luis Fayad, Felipe Samaniego, Hans C Lee, Loretta J Nastoupil, Nathan Fowler, R Eric Davis, Jason Westin, Sattva S Neelapu, Linghua Wang, Michael R Green
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nature medicine 26 (12) (2020)
Elisabet E Manasanch, Guangchun Han, Rohit Mathur, Yun Qing, Zheng Zhang, Hans C Lee, Donna M Weber, Behrang Amini, Zuzana Berkova, Karina Eterovic, Shaojun Zhang, Jianhua Zhang, Xingzhi Song, Xizeng Mao, Margaret Morgan, Lei Feng, Veera Baladandayuthapani, Andrew Futreal, Linghua Wang, Sattva S Neelapu, Robert Z Orlowski
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood advances 3 (15) (2020)
Sattva S Neelapu
CAR-T efficacy: is conditioning the key? Blood 133 (17) (2019)

Sattva S Neelapu.css-eqlu8i{font-size:small;padding-left:4px;} (Sattva Neelapu)

Publication Activity (10 Years)

Top Topics

Top Venues

Sattva S Neelapu (Sattva Neelapu)